These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
284 related articles for article (PubMed ID: 27644987)
1. Hepatocellular carcinoma redirects to ketolysis for progression under nutrition deprivation stress. Huang D; Li T; Wang L; Zhang L; Yan R; Li K; Xing S; Wu G; Hu L; Jia W; Lin SC; Dang CV; Song L; Gao P; Zhang H Cell Res; 2016 Oct; 26(10):1112-1130. PubMed ID: 27644987 [TBL] [Abstract][Full Text] [Related]
2. Targeting OXCT1-mediated ketone metabolism reprograms macrophages to promote antitumor immunity via CD8 Zhu CX; Yan K; Chen L; Huang RR; Bian ZH; Wei HR; Gu XM; Zhao YY; Liu MC; Suo CX; Li ZK; Yang ZY; Lu MQ; Hua XF; Li L; Zhao ZB; Sun LC; Zhang HF; Gao P; Lian ZX J Hepatol; 2024 Oct; 81(4):690-703. PubMed ID: 38759889 [TBL] [Abstract][Full Text] [Related]
3. AKT activation was not essential for hepatocellular carcinoma cell survival under glucose deprivation. Zhou J; Tang Y; Xie ZJ; Lu JN; Deng JH; Huang XW; Chuan Hooi S; He M; Lu GD Anticancer Drugs; 2017 Apr; 28(4):427-435. PubMed ID: 28085697 [TBL] [Abstract][Full Text] [Related]
4. Activation of AKT pathway by Nrf2/PDGFA feedback loop contributes to HCC progression. Liu D; Zhang Y; Wei Y; Liu G; Liu Y; Gao Q; Zou L; Zeng W; Zhang N Oncotarget; 2016 Oct; 7(40):65389-65402. PubMed ID: 27588483 [TBL] [Abstract][Full Text] [Related]
5. G-Protein-Coupled Estrogen Receptor 1 Promotes Gender Disparities in Hepatocellular Carcinoma via Modulation of SIN1 and mTOR Complex 2 Activity. Feng G; Cai J; Huang Y; Zhu X; Gong B; Yang Z; Yan C; Hu Z; Yang L; Wang Z Mol Cancer Res; 2020 Dec; 18(12):1863-1875. PubMed ID: 32873626 [TBL] [Abstract][Full Text] [Related]
6. Obligate role for ketone body oxidation in neonatal metabolic homeostasis. Cotter DG; d'Avignon DA; Wentz AE; Weber ML; Crawford PA J Biol Chem; 2011 Mar; 286(9):6902-10. PubMed ID: 21209089 [TBL] [Abstract][Full Text] [Related]
7. Acetylcholinesterase, a key prognostic predictor for hepatocellular carcinoma, suppresses cell growth and induces chemosensitization. Zhao Y; Wang X; Wang T; Hu X; Hui X; Yan M; Gao Q; Chen T; Li J; Yao M; Wan D; Gu J; Fan J; He X Hepatology; 2011 Feb; 53(2):493-503. PubMed ID: 21274871 [TBL] [Abstract][Full Text] [Related]
8. MiR-21 mediates sorafenib resistance of hepatocellular carcinoma cells by inhibiting autophagy via the PTEN/Akt pathway. He C; Dong X; Zhai B; Jiang X; Dong D; Li B; Jiang H; Xu S; Sun X Oncotarget; 2015 Oct; 6(30):28867-81. PubMed ID: 26311740 [TBL] [Abstract][Full Text] [Related]
9. The HGF-MET axis coordinates liver cancer metabolism and autophagy for chemotherapeutic resistance. Huang X; Gan G; Wang X; Xu T; Xie W Autophagy; 2019 Jul; 15(7):1258-1279. PubMed ID: 30786811 [TBL] [Abstract][Full Text] [Related]
10. Low ketolytic enzyme levels in tumors predict ketogenic diet responses in cancer cell lines in vitro and in vivo. Zhang J; Jia PP; Liu QL; Cong MH; Gao Y; Shi HP; Yu WN; Miao MY J Lipid Res; 2018 Apr; 59(4):625-634. PubMed ID: 29414764 [TBL] [Abstract][Full Text] [Related]
11. Combination of cetuximab and rapamycin enhances the therapeutic efficacy in hepatocellular carcinoma. Geng J; Li X; Lang X; Qiao C; Hu M; Yang J; Feng J; Lv M Technol Cancer Res Treat; 2014 Aug; 13(4):377-85. PubMed ID: 24325131 [TBL] [Abstract][Full Text] [Related]
12. Choline Kinase α Mediates Interactions Between the Epidermal Growth Factor Receptor and Mechanistic Target of Rapamycin Complex 2 in Hepatocellular Carcinoma Cells to Promote Drug Resistance and Xenograft Tumor Progression. Lin XM; Hu L; Gu J; Wang RY; Li L; Tang J; Zhang BH; Yan XZ; Zhu YJ; Hu CL; Zhou WP; Li S; Liu JF; Gonzalez FJ; Wu MC; Wang HY; Chen L Gastroenterology; 2017 Apr; 152(5):1187-1202. PubMed ID: 28065789 [TBL] [Abstract][Full Text] [Related]
13. α-Humulene inhibits hepatocellular carcinoma cell proliferation and induces apoptosis through the inhibition of Akt signaling. Chen H; Yuan J; Hao J; Wen Y; Lv Y; Chen L; Yang X Food Chem Toxicol; 2019 Dec; 134():110830. PubMed ID: 31562948 [TBL] [Abstract][Full Text] [Related]
14. Interaction of KLF6 and Sp1 regulates basigin-2 expression mediated proliferation, invasion and metastasis in hepatocellular carcinoma. Kong LM; Yao L; Lu N; Dong YL; Zhang J; Wang YQ; Liu L; Zhang HL; Huang JG; Liao CG Oncotarget; 2016 May; 7(19):27975-87. PubMed ID: 27057625 [TBL] [Abstract][Full Text] [Related]
15. HBx regulates fatty acid oxidation to promote hepatocellular carcinoma survival during metabolic stress. Wang MD; Wu H; Huang S; Zhang HL; Qin CJ; Zhao LH; Fu GB; Zhou X; Wang XM; Tang L; Wen W; Yang W; Tang SH; Cao D; Guo LN; Zeng M; Wu MC; Yan HX; Wang HY Oncotarget; 2016 Feb; 7(6):6711-26. PubMed ID: 26744319 [TBL] [Abstract][Full Text] [Related]
16. Hydrogen sulfide promotes autophagy of hepatocellular carcinoma cells through the PI3K/Akt/mTOR signaling pathway. Wang SS; Chen YH; Chen N; Wang LJ; Chen DX; Weng HL; Dooley S; Ding HG Cell Death Dis; 2017 Mar; 8(3):e2688. PubMed ID: 28333142 [TBL] [Abstract][Full Text] [Related]
17. Des-gamma-carboxy prothrombin antagonizes the effects of Sorafenib on human hepatocellular carcinoma through activation of the Raf/MEK/ERK and PI3K/Akt/mTOR signaling pathways. Cui SX; Shi WN; Song ZY; Wang SQ; Yu XF; Gao ZH; Qu XJ Oncotarget; 2016 Jun; 7(24):36767-36782. PubMed ID: 27167344 [TBL] [Abstract][Full Text] [Related]
18. Eukaryotic elongation factor 2 kinase promotes angiogenesis in hepatocellular carcinoma via PI3K/Akt and STAT3. Zhou Y; Li Y; Xu S; Lu J; Zhu Z; Chen S; Tan Y; He P; Xu J; Proud CG; Xie J; Shen K Int J Cancer; 2020 Mar; 146(5):1383-1395. PubMed ID: 31286509 [TBL] [Abstract][Full Text] [Related]
19. Connexin32 regulates hepatoma cell metastasis and proliferation via the p53 and Akt pathways. Zhao B; Zhao W; Wang Y; Xu Y; Xu J; Tang K; Zhang S; Yin Z; Wu Q; Wang X Oncotarget; 2015 Apr; 6(12):10116-33. PubMed ID: 25426556 [TBL] [Abstract][Full Text] [Related]
20. Artemisia capillaris extract AC68 induces apoptosis of hepatocellular carcinoma by blocking the PI3K/AKT pathway. Yan H; Jung KH; Kim J; Rumman M; Oh MS; Hong SS Biomed Pharmacother; 2018 Feb; 98():134-141. PubMed ID: 29253760 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]